Add-on exercise interventions for smoking cessation in people with mental illness: a systematic review and meta-analysis.
Exercise
Mental disorder
Mental illness
Meta-analysis
Physical activity
Smoking
Smoking cessation
Systematic review
Journal
BMC sports science, medicine & rehabilitation
ISSN: 2052-1847
Titre abrégé: BMC Sports Sci Med Rehabil
Pays: England
ID NLM: 101605016
Informations de publication
Date de publication:
21 Jun 2022
21 Jun 2022
Historique:
received:
14
12
2021
accepted:
07
06
2022
entrez:
21
6
2022
pubmed:
22
6
2022
medline:
22
6
2022
Statut:
epublish
Résumé
Smoking is the most common substance use disorder among people with mental illness. In contrast to people without mental illness, among whom the proportion of smokers has declined in recent decades, the proportion of smokers among people with mental illness remains high. There is a growing body of literature suggesting the use of exercise interventions in combination with smoking cessation in people without mental illness, but to our knowledge the available studies on this treatment option in people with mental illness have not been systematically reviewed. Therefore, this systematic review and meta-analysis aims to assess the effectiveness of exercise interventions as an adjunctive treatment for smoking cessation in people with mental illness. Electronic databases (PubMed, Web of Science, PsycInfo, Sport Discus and Base) were searched for randomised controlled trials and prospective single-group studies that investigated exercise interventions in combination with smoking cessation programmes alone or in comparison with a control group in people with mental illness. A meta-analysis using the Mantel-Haenszel fixed-effect model was conducted to estimate the overall effect of treatment on smoking cessation (abstinence rate at the end of the intervention and at 6-month follow-up). Six studies, five randomised controlled trials and one study with a prospective single-group design, were included in the systematic review and four randomised controlled trials were included in the meta-analysis. The meta-analysis found a significantly higher abstinence rate after additional exercise at the end of the intervention [risk ratio (RR) 1.48, 95% confidence interval (CI) 1.13-1.94], but not at the 6-month follow-up (RR 1.34, 95% CI 0.89-2.04). Exercise appears to be an effective adjunctive therapy to temporarily increase abstinence rates in individuals with mental illness at the end of the intervention. However, due to the small number of included studies and some risk of bias in the included studies, the results should be treated with caution. Therefore, future studies with larger samples are needed to provide a more accurate estimate of the effect in people with mental illness. Registration The systematic review and meta-analysis were registered in the International Prospective Register of Systematic Reviews (PROSPERO) (registration number: CRD42020178630).
Sections du résumé
BACKGROUND
BACKGROUND
Smoking is the most common substance use disorder among people with mental illness. In contrast to people without mental illness, among whom the proportion of smokers has declined in recent decades, the proportion of smokers among people with mental illness remains high. There is a growing body of literature suggesting the use of exercise interventions in combination with smoking cessation in people without mental illness, but to our knowledge the available studies on this treatment option in people with mental illness have not been systematically reviewed. Therefore, this systematic review and meta-analysis aims to assess the effectiveness of exercise interventions as an adjunctive treatment for smoking cessation in people with mental illness.
METHODS
METHODS
Electronic databases (PubMed, Web of Science, PsycInfo, Sport Discus and Base) were searched for randomised controlled trials and prospective single-group studies that investigated exercise interventions in combination with smoking cessation programmes alone or in comparison with a control group in people with mental illness. A meta-analysis using the Mantel-Haenszel fixed-effect model was conducted to estimate the overall effect of treatment on smoking cessation (abstinence rate at the end of the intervention and at 6-month follow-up).
RESULTS
RESULTS
Six studies, five randomised controlled trials and one study with a prospective single-group design, were included in the systematic review and four randomised controlled trials were included in the meta-analysis. The meta-analysis found a significantly higher abstinence rate after additional exercise at the end of the intervention [risk ratio (RR) 1.48, 95% confidence interval (CI) 1.13-1.94], but not at the 6-month follow-up (RR 1.34, 95% CI 0.89-2.04).
CONCLUSIONS
CONCLUSIONS
Exercise appears to be an effective adjunctive therapy to temporarily increase abstinence rates in individuals with mental illness at the end of the intervention. However, due to the small number of included studies and some risk of bias in the included studies, the results should be treated with caution. Therefore, future studies with larger samples are needed to provide a more accurate estimate of the effect in people with mental illness. Registration The systematic review and meta-analysis were registered in the International Prospective Register of Systematic Reviews (PROSPERO) (registration number: CRD42020178630).
Identifiants
pubmed: 35729669
doi: 10.1186/s13102-022-00498-y
pii: 10.1186/s13102-022-00498-y
pmc: PMC9210718
doi:
Types de publication
Journal Article
Langues
eng
Pagination
115Subventions
Organisme : Oesterreichische Nationalbank
ID : project number: 17942
Informations de copyright
© 2022. The Author(s).
Références
Acta Psychiatr Scand. 2015 Aug;132(2):122-30
pubmed: 25754402
Addiction. 2013 Jan;108(1):26-37
pubmed: 22861822
J Physiother. 2015 Jul;61(3):165-7
pubmed: 26096012
Nicotine Tob Res. 2013 Oct;15(10):1635-50
pubmed: 23535556
J Dual Diagn. 2015;11(3-4):205-16
pubmed: 26683252
Nicotine Tob Res. 2014 Aug;16(8):1094-103
pubmed: 24812023
Neurosci Biobehav Rev. 2012 Jan;36(1):271-84
pubmed: 21723317
Psychiatry Res. 2010 Mar 30;176(1):13-6
pubmed: 20079934
Psychiatr Serv. 2007 Mar;58(3):405-8
pubmed: 17325117
Psychopharmacology (Berl). 2012 Jul;222(1):1-15
pubmed: 22585034
BMC Psychiatry. 2017 Jul 14;17(1):252
pubmed: 28705244
Nicotine Tob Res. 2017 Jan;19(1):77-86
pubmed: 27613946
Addiction. 2020 Nov;115(11):2008-2020
pubmed: 32196796
Am J Med. 2020 Jun;133(6):741-749
pubmed: 31982494
Sports Med Open. 2019 Sep 03;5(1):39
pubmed: 31482208
Psychosom Med. 2016 Apr;78(3):354-64
pubmed: 26513517
Schizophr Res. 2011 Mar;126(1-3):277-83
pubmed: 21112185
Schizophr Res. 2010 Mar;117(1):75-82
pubmed: 20080392
Addiction. 2005 Mar;100(3):299-303
pubmed: 15733243
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Trials. 2016 Oct 27;17(1):524
pubmed: 27788686
Eur Child Adolesc Psychiatry. 2017 Jan;26(1):111-122
pubmed: 27277894
J Consult Clin Psychol. 2018 May;86(5):474-485
pubmed: 29683703
Schizophr Res. 2002 Jul 1;56(1-2):47-54
pubmed: 12084419
Neuropsychiatr. 2012;26(4):166-70
pubmed: 23111811
Med Care. 2011 Jun;49(6):599-604
pubmed: 21577183
BMC Res Notes. 2017 Sep 6;10(1):442
pubmed: 28874175
Tob Control. 2010 Dec;19(6):488-94
pubmed: 20798023
Addiction. 2007 Apr;102(4):534-43
pubmed: 17286639
Addict Behav. 2004 Aug;29(6):1067-83
pubmed: 15236808
Ann Behav Med. 2014 Oct;48(2):194-204
pubmed: 24604528
Psychiatry Res. 2007 Mar 30;150(2):141-52
pubmed: 17289155
Addiction. 2020 Sep;115(9):1607-1617
pubmed: 32043675
Prog Cardiovasc Dis. 2018 Nov - Dec;61(5-6):484-490
pubmed: 30445160
Prim Health Care Res Dev. 2017 Sep;18(5):463-471
pubmed: 28653595
J Womens Health (Larchmt). 2012 Feb;21(2):240-8
pubmed: 21992583
J Subst Abuse Treat. 2017 Sep;80:37-44
pubmed: 28755771
Nicotine Tob Res. 2011 Aug;13(8):756-60
pubmed: 21504883
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
BMC Public Health. 2009 Aug 07;9:285
pubmed: 19664203
Addiction. 2011 Feb;106(2):418-27
pubmed: 20973856
JAMA. 2014 Jan 8;311(2):172-82
pubmed: 24399556
Schizophr Bull. 2016 Jan;42(1):96-124
pubmed: 26221050
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Addiction. 2021 Nov;116(11):3188-3197
pubmed: 34033178
Arch Psychiatr Nurs. 2013 Feb;27(1):23-31
pubmed: 23352022
Nicotine Tob Res. 2009 Aug;11(8):985-95
pubmed: 19541948
Health Psychol. 2018 Jul;37(7):647-657
pubmed: 29708388
Psychol Med. 2016 Oct;46(14):2869-2881
pubmed: 27502153
Prev Med. 2007 Dec;45(6):401-15
pubmed: 17707498
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Gen Hosp Psychiatry. 2015 Jan-Feb;37(1):14-23
pubmed: 25510845
Cochrane Database Syst Rev. 2019 Oct 30;2019(10):
pubmed: 31684691
Nicotine Tob Res. 2013 Jun;15(6):1014-31
pubmed: 23100459
PLoS One. 2017 Dec 5;12(12):e0188849
pubmed: 29206852
Lancet Respir Med. 2016 Oct;4(10):835-844
pubmed: 27707462
Schizophr Res. 2005 Jul 15;76(2-3):135-57
pubmed: 15949648
Schizophr Res. 2016 Mar;171(1-3):42-9
pubmed: 26822592
ScientificWorldJournal. 2012;2012:901741
pubmed: 22629222
Health Technol Assess. 2014 Jan;18(4):1-324
pubmed: 24433837
Am J Psychiatry. 2006 Nov;163(11):1934-42
pubmed: 17074945
Addiction. 2009 May;104(5):719-33
pubmed: 19413788
J Sci Med Sport. 2015 Sep;18(5):534-9
pubmed: 25108657
World Psychiatry. 2020 Oct;19(3):360-380
pubmed: 32931092
Am J Prev Med. 2016 Dec;51(6):958-966
pubmed: 27522471
Drug Alcohol Depend. 2019 Jan 1;194:128-135
pubmed: 30439609
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120